NasdaqCM - Delayed Quote USD

Haoxi Health Technology Limited (HAO)

Compare
0.1860 -0.0044 (-2.31%)
At close: October 23 at 4:00 PM EDT
0.1898 +0.00 (+2.04%)
After hours: October 23 at 7:46 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
Total Revenue
28,229.1490
28,229.1490
16,156.8650
12,847.5450
Cost of Revenue
26,167.0830
26,167.0830
15,508.1440
12,241.9680
Gross Profit
2,062.0660
2,062.0660
648.7210
605.5770
Operating Expense
866.2550
866.2550
379.9530
275.0230
Operating Income
1,195.8110
1,195.8110
268.7680
330.5540
Net Non Operating Interest Income Expense
-20.9020
-20.9020
-9.9610
-5.2700
Other Income Expense
15.4960
15.4960
0.7880
--
Pretax Income
1,190.4050
1,190.4050
259.5950
325.2840
Tax Provision
220.6530
220.6530
15.0080
21.2190
Net Income Common Stockholders
969.7520
969.7520
244.5870
304.0650
Diluted NI Available to Com Stockholders
969.7520
969.7520
244.5870
304.0650
Basic EPS
0.07
--
0.02
0.01
Diluted EPS
0.07
--
0.02
0.01
Basic Average Shares
14,610.0000
--
14,610.0000
29,480.0000
Diluted Average Shares
31,880.0000
--
14,610.0000
29,480.0000
Total Operating Income as Reported
1,195.8110
1,195.8110
268.7680
330.5540
Total Expenses
27,033.3380
27,033.3380
15,888.0970
12,516.9910
Net Income from Continuing & Discontinued Operation
969.7520
969.7520
244.5870
304.0650
Normalized Income
969.7520
969.7520
244.5870
304.0650
Interest Expense
20.9020
20.9020
9.9610
5.2700
Net Interest Income
-20.9020
-20.9020
-9.9610
-5.2700
EBIT
1,211.3070
1,211.3070
269.5560
330.5540
EBITDA
1,219.7000
1,219.7000
271.7680
330.9650
Reconciled Cost of Revenue
26,167.0830
26,167.0830
15,508.1440
12,241.9680
Reconciled Depreciation
8.3930
8.3930
2.2120
0.4110
Net Income from Continuing Operation Net Minority Interest
969.7520
969.7520
244.5870
304.0650
Normalized EBITDA
1,219.7000
1,219.7000
271.7680
330.9650
Tax Rate for Calcs
0.0002
0.0002
0.0001
0.0001
6/30/2021 - 1/26/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers